{"entryType":"UniProtKB reviewed (Swiss-Prot)","primaryAccession":"P69723","secondaryAccessions":["P03401"],"uniProtkbId":"VIF_HV1H2","entryAudit":{"firstPublicDate":"1986-07-21","lastAnnotationUpdateDate":"2022-12-14","lastSequenceUpdateDate":"1987-08-13","entryVersion":112,"sequenceVersion":1},"annotationScore":5.0,"organism":{"scientificName":"Human immunodeficiency virus type 1 group M subtype B (isolate HXB2)","commonName":"HIV-1","taxonId":11706,"lineage":["Viruses","Riboviria","Pararnavirae","Artverviricota","Revtraviricetes","Ortervirales","Retroviridae","Orthoretrovirinae","Lentivirus"]},"organismHosts":[{"scientificName":"Homo sapiens","commonName":"Human","taxonId":9606}],"proteinExistence":"1: Evidence at protein level","proteinDescription":{"recommendedName":{"fullName":{"evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04081"}],"value":"Virion infectivity factor"},"shortNames":[{"evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04081"}],"value":"Vif"}]},"alternativeNames":[{"fullName":{"evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04081"}],"value":"SOR protein"}}],"contains":[{"recommendedName":{"fullName":{"evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04081"}],"value":"p17"}}},{"recommendedName":{"fullName":{"evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04081"}],"value":"p7"}}}]},"genes":[{"geneName":{"evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04081"}],"value":"vif"}}],"comments":[{"texts":[{"evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04081"},{"evidenceCode":"ECO:0000269","source":"PubMed","id":"14564014"},{"evidenceCode":"ECO:0000269","source":"PubMed","id":"14672928"},{"evidenceCode":"ECO:0000269","source":"PubMed","id":"17056089"},{"evidenceCode":"ECO:0000269","source":"PubMed","id":"19910370"},{"evidenceCode":"ECO:0000269","source":"PubMed","id":"8970997"}],"value":"Counteracts the innate antiviral activity of host APOBEC3F and APOBEC3G. Forms a complex with host APOBEC3F and APOBEC3G thus preventing the entry of these lethally hypermutating enzymes into progeny virions. Recruits an active E3 ubiquitin ligase complex composed of elongin BC, CUL5, and RBX2 to induce polyubiquitination of APOBEC3G and APOBEC3F. In turn, they are directed to the 26S proteasome for degradation. Vif interaction with APOBEC3G also blocks its cytidine deaminase activity in a proteasome-independent manner, suggesting a dual inhibitory mechanism. May interact directly with APOBEC3G mRNA in order to inhibit its translation. Seems to play a role in viral morphology by affecting the stability of the viral nucleoprotein core. Finally, Vif also contributes to the G2 cell cycle arrest observed in HIV infected cells"}],"commentType":"FUNCTION"},{"texts":[{"evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04081"},{"evidenceCode":"ECO:0000269","source":"PubMed","id":"15752743"},{"evidenceCode":"ECO:0000269","source":"PubMed","id":"17522216"},{"evidenceCode":"ECO:0000269","source":"PubMed","id":"18619467"},{"evidenceCode":"ECO:0000269","source":"PubMed","id":"19128510"},{"evidenceCode":"ECO:0000269","source":"PubMed","id":"19369217"},{"evidenceCode":"ECO:0000269","source":"PubMed","id":"9371595"}],"value":"Homomultimer; in vitro and presumably in vivo. Interacts with viral RNA and Pr55Gag precursor; these interactions mediate Vif incorporation into the virion. Interacts with the viral reverse transcriptase. Interacts with human APOBEC3F and APOBEC3G. Interacts with host UBCE7IP1 isoform 3/ZIN and possibly with SAT. Interacts with host tyrosine kinases HCK and FYN; these interactions may decrease level of phosphorylated APOBEC3G incorporation into virions. Interacts with host ABCE1; this interaction may play a role in protecting viral RNA from damage during viral assembly. Forms an E3 ligase complex by interacting with host CUL5 and elongin BC complex (ELOB and ELOC). Interacts with host MDM2; this interaction targets Vif for degradation by the proteasome"}],"commentType":"SUBUNIT"},{"commentType":"INTERACTION","interactions":[{"interactantOne":{"uniProtKBAccession":"P69723","intActId":"EBI-15528966"},"interactantTwo":{"uniProtKBAccession":"P69723","geneName":"vif","intActId":"EBI-15528966"},"numberOfExperiments":4,"organismDiffer":false},{"interactantOne":{"uniProtKBAccession":"P69723","intActId":"EBI-15528966"},"interactantTwo":{"uniProtKBAccession":"Q9HC16","geneName":"APOBEC3G","intActId":"EBI-717839"},"numberOfExperiments":3,"organismDiffer":true}]},{"commentType":"SUBCELLULAR LOCATION","note":{"texts":[{"evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04081"}],"value":"In the cytoplasm, seems to colocalize with intermediate filament vimentin. A fraction is associated with the cytoplasmic side of cellular membranes, presumably via the interaction with Pr55Gag precursor. Incorporated in virions at a ratio of approximately 7 to 20 molecules per virion"}]},"subcellularLocations":[{"location":{"evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04081"}],"value":"Host cytoplasm","id":"SL-0381"}},{"location":{"evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04081"}],"value":"Host cell membrane","id":"SL-0375"},"topology":{"evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04081"}],"value":"Peripheral membrane protein","id":"SL-9903"},"orientation":{"evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04081"}],"value":"Cytoplasmic side","id":"SL-9910"}},{"location":{"evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04081"}],"value":"Virion","id":"SL-0274"}}]},{"texts":[{"evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04081"}],"value":"Expressed late during infection in a Rev-dependent manner"}],"commentType":"INDUCTION"},{"texts":[{"evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04081"}],"value":"The BC-like-box motif mediates the interaction with elongin BC complex"}],"commentType":"DOMAIN"},{"texts":[{"evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04081"}],"value":"The HCCH motif (H-x(5)-C-x(18)-C-x(5)-H) mediates the interaction with CUL5"}],"commentType":"DOMAIN"},{"texts":[{"evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04081"},{"evidenceCode":"ECO:0000269","source":"PubMed","id":"8626571"},{"evidenceCode":"ECO:0000269","source":"PubMed","id":"9792705"}],"value":"Highly phosphorylated on serine and threonine residues (By similarity). Thr-96 and Ser-165 are phosphorylated by the mitogen activated kinase MAP4K1. As the HIV-1 replication can be activated by stress and mitogens, these phosphorylations could be involved in this process. Ser-144 phosphorylation may inhibit elongin BC complex binding"}],"commentType":"PTM"},{"texts":[{"evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04081"}],"value":"Processed in virion by the viral protease"}],"commentType":"PTM"},{"texts":[{"evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04081"}],"value":"Polyubiquitinated and degraded by the proteasome in the presence of APOBEC3G"}],"commentType":"PTM"},{"texts":[{"evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04081"}],"value":"Vif-defective viruses show catastrophic failure in reverse transcription due to APOBEC-induced mutations that initiate a DNA base repair pathway and compromise the structural integrity of the ssDNA. In the absence of Vif, the virion is morphologically abnormal"}],"commentType":"MISCELLANEOUS"},{"texts":[{"evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04081"}],"value":"HIV-1 lineages are divided in three main groups, M (for Major), O (for Outlier), and N (for New, or Non-M, Non-O). The vast majority of strains found worldwide belong to the group M. Group O seems to be endemic to and largely confined to Cameroon and neighboring countries in West Central Africa, where these viruses represent a small minority of HIV-1 strains. The group N is represented by a limited number of isolates from Cameroonian persons. The group M is further subdivided in 9 clades or subtypes (A to D, F to H, J and K)"}],"commentType":"MISCELLANEOUS"},{"texts":[{"evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04081"}],"value":"Required for replication in 'nonpermissive' cells, including primary T-cells, macrophages and certain T-cell lines, but is dispensable for replication in 'permissive' cell lines, such as 293T cells. In nonpermissive cells, Vif-defective viruses can produce virions, but they fail to complete reverse transcription and cannot successfully infect new cells"}],"commentType":"MISCELLANEOUS"},{"texts":[{"evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04081"},{"evidenceCode":"ECO:0000305"}],"value":"Belongs to the primate lentivirus group Vif protein family"}],"commentType":"SIMILARITY"}],"features":[{"type":"Chain","location":{"start":{"value":1,"modifier":"EXACT"},"end":{"value":192,"modifier":"EXACT"}},"description":"Virion infectivity factor","evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04081"}],"featureId":"PRO_0000042759"},{"type":"Chain","location":{"start":{"value":1,"modifier":"EXACT"},"end":{"value":150,"modifier":"EXACT"}},"description":"p17","evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04081"}],"featureId":"PRO_0000042760"},{"type":"Chain","location":{"start":{"value":151,"modifier":"EXACT"},"end":{"value":192,"modifier":"EXACT"}},"description":"p7","evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04081"}],"featureId":"PRO_0000042761"},{"type":"Region","location":{"start":{"value":14,"modifier":"EXACT"},"end":{"value":17,"modifier":"EXACT"}},"description":"Interaction with host APOBEC3F; F1-box","evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04081"}]},{"type":"Region","location":{"start":{"value":40,"modifier":"EXACT"},"end":{"value":44,"modifier":"EXACT"}},"description":"Interaction with host APOBEC3G; G-box","evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04081"}]},{"type":"Region","location":{"start":{"value":54,"modifier":"EXACT"},"end":{"value":72,"modifier":"EXACT"}},"description":"Interaction with host APOBEC3F and APOBEC3G; FG-box","evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04081"}]},{"type":"Region","location":{"start":{"value":74,"modifier":"EXACT"},"end":{"value":79,"modifier":"EXACT"}},"description":"Interaction with host APOBEC3F; F2-box","evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04081"}]},{"type":"Region","location":{"start":{"value":75,"modifier":"EXACT"},"end":{"value":114,"modifier":"EXACT"}},"description":"RNA-binding","evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04081"}]},{"type":"Region","location":{"start":{"value":151,"modifier":"EXACT"},"end":{"value":164,"modifier":"EXACT"}},"description":"Multimerization","evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04081"}]},{"type":"Region","location":{"start":{"value":164,"modifier":"EXACT"},"end":{"value":192,"modifier":"EXACT"}},"description":"Disordered","evidences":[{"evidenceCode":"ECO:0000256","source":"SAM","id":"MobiDB-lite"}]},{"type":"Region","location":{"start":{"value":171,"modifier":"EXACT"},"end":{"value":172,"modifier":"EXACT"}},"description":"Membrane association","evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04081"}]},{"type":"Motif","location":{"start":{"value":108,"modifier":"EXACT"},"end":{"value":139,"modifier":"EXACT"}},"description":"HCCH motif","evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04081"}]},{"type":"Motif","location":{"start":{"value":144,"modifier":"EXACT"},"end":{"value":153,"modifier":"EXACT"}},"description":"BC-box-like motif","evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04081"}]},{"type":"Site","location":{"start":{"value":150,"modifier":"EXACT"},"end":{"value":151,"modifier":"EXACT"}},"description":"Cleavage in virion (by viral protease)","evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04081"}]},{"type":"Modified residue","location":{"start":{"value":96,"modifier":"EXACT"},"end":{"value":96,"modifier":"EXACT"}},"description":"Phosphothreonine; by host MAP4K1","evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04081"},{"evidenceCode":"ECO:0000269","source":"PubMed","id":"9792705"}]},{"type":"Modified residue","location":{"start":{"value":144,"modifier":"EXACT"},"end":{"value":144,"modifier":"EXACT"}},"description":"Phosphoserine; by host","evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04081"},{"evidenceCode":"ECO:0000269","source":"PubMed","id":"8626571"}]},{"type":"Modified residue","location":{"start":{"value":155,"modifier":"EXACT"},"end":{"value":155,"modifier":"EXACT"}},"description":"Phosphothreonine; by host","evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04081"},{"evidenceCode":"ECO:0000269","source":"PubMed","id":"8626571"}]},{"type":"Modified residue","location":{"start":{"value":165,"modifier":"EXACT"},"end":{"value":165,"modifier":"EXACT"}},"description":"Phosphoserine; by host MAP4K1","evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04081"},{"evidenceCode":"ECO:0000269","source":"PubMed","id":"9792705"}]},{"type":"Modified residue","location":{"start":{"value":188,"modifier":"EXACT"},"end":{"value":188,"modifier":"EXACT"}},"description":"Phosphothreonine; by host","evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04081"},{"evidenceCode":"ECO:0000269","source":"PubMed","id":"8626571"}]},{"type":"Mutagenesis","location":{"start":{"value":96,"modifier":"EXACT"},"end":{"value":96,"modifier":"EXACT"}},"description":"90% loss of reverse transcriptase activity in virions; no effect on the ability to decrease APOBEC3G level.","evidences":[{"evidenceCode":"ECO:0000269","source":"PubMed","id":"9792705"}],"alternativeSequence":{"originalSequence":"T","alternativeSequences":["A"]}},{"type":"Mutagenesis","location":{"start":{"value":96,"modifier":"EXACT"},"end":{"value":96,"modifier":"EXACT"}},"description":"Complete loss of viral infectivity in non permissive cells; no effect on the ability to decrease APOBEC3G level.","evidences":[{"evidenceCode":"ECO:0000269","source":"PubMed","id":"9792705"}],"alternativeSequence":{"originalSequence":"T","alternativeSequences":["E"]}},{"type":"Mutagenesis","location":{"start":{"value":114,"modifier":"EXACT"},"end":{"value":114,"modifier":"EXACT"}},"description":"Reduces the ability to decrease APOBEC3G level; when associated with S-133.","evidences":[{"evidenceCode":"ECO:0000269","source":"PubMed","id":"14672928"}],"alternativeSequence":{"originalSequence":"C","alternativeSequences":["S"]}},{"type":"Mutagenesis","location":{"start":{"value":133,"modifier":"EXACT"},"end":{"value":133,"modifier":"EXACT"}},"description":"Reduces the ability to decrease APOBEC3G level; when associated with S-114.","evidences":[{"evidenceCode":"ECO:0000269","source":"PubMed","id":"14672928"}],"alternativeSequence":{"originalSequence":"C","alternativeSequences":["S"]}},{"type":"Mutagenesis","location":{"start":{"value":144,"modifier":"EXACT"},"end":{"value":144,"modifier":"EXACT"}},"description":"90% loss of viral infectivity in non permissive cells; no effect on the ability to decrease APOBEC3G level.","evidences":[{"evidenceCode":"ECO:0000269","source":"PubMed","id":"8626571"}],"alternativeSequence":{"originalSequence":"S","alternativeSequences":["A"]}},{"type":"Mutagenesis","location":{"start":{"value":157,"modifier":"EXACT"},"end":{"value":160,"modifier":"EXACT"}},"description":"75% loss of membrane binding; decrease Pr55Gag binding.","evidences":[{"evidenceCode":"ECO:0000269","source":"PubMed","id":"7474141"}],"alternativeSequence":{"originalSequence":"KKIK","alternativeSequences":["AAIA"]}},{"type":"Mutagenesis","location":{"start":{"value":173,"modifier":"EXACT"},"end":{"value":179,"modifier":"EXACT"}},"description":"40% loss of membrane binding; decrease Pr55Gag binding.","alternativeSequence":{"originalSequence":"RWNKPQK","alternativeSequences":["AWNAPQA"]}},{"type":"Mutagenesis","location":{"start":{"value":179,"modifier":"EXACT"},"end":{"value":184,"modifier":"EXACT"}},"description":"25% loss of membrane binding; decrease Pr55Gag binding.","alternativeSequence":{"originalSequence":"KTKGHR","alternativeSequences":["ATAGHA"]}},{"type":"Mutagenesis","location":{"start":{"value":188,"modifier":"EXACT"},"end":{"value":188,"modifier":"EXACT"}},"description":"No effect on the ability to decrease APOBEC3G level.","evidences":[{"evidenceCode":"ECO:0000269","source":"PubMed","id":"14672928"}],"alternativeSequence":{"originalSequence":"T","alternativeSequences":["A"]}}],"keywords":[{"id":"KW-0014","category":"Disease","name":"AIDS"},{"id":"KW-0903","category":"Technical term","name":"Direct protein sequencing"},{"id":"KW-1032","category":"Cellular component","name":"Host cell membrane"},{"id":"KW-1035","category":"Cellular component","name":"Host cytoplasm"},{"id":"KW-1043","category":"Cellular component","name":"Host membrane"},{"id":"KW-0945","category":"Biological process","name":"Host-virus interaction"},{"id":"KW-0472","category":"Cellular component","name":"Membrane"},{"id":"KW-0597","category":"PTM","name":"Phosphoprotein"},{"id":"KW-1185","category":"Technical term","name":"Reference proteome"},{"id":"KW-0694","category":"Molecular function","name":"RNA-binding"},{"id":"KW-0832","category":"PTM","name":"Ubl conjugation"},{"id":"KW-0833","category":"Biological process","name":"Ubl conjugation pathway"},{"id":"KW-0946","category":"Cellular component","name":"Virion"}],"references":[{"citation":{"id":"3040055","citationType":"journal article","authors":["Ratner L.","Fisher A.","Jagodzinski L.L.","Mitsuya H.","Liou R.-S.","Gallo R.C.","Wong-Staal F."],"citationCrossReferences":[{"database":"PubMed","id":"3040055"},{"database":"DOI","id":"10.1089/aid.1987.3.57"}],"title":"Complete nucleotide sequences of functional clones of the AIDS virus.","publicationDate":"1987","journal":"AIDS Res. Hum. Retroviruses","firstPage":"57","lastPage":"69","volume":"3"},"referencePositions":["NUCLEOTIDE SEQUENCE [GENOMIC RNA]"]},{"citation":{"id":"8289374","citationType":"journal article","authors":["Goncalves J.","Jallepalli P.","Gabuzda D.H."],"citationCrossReferences":[{"database":"PubMed","id":"8289374"},{"database":"DOI","id":"10.1128/jvi.68.2.704-712.1994"}],"title":"Subcellular localization of the Vif protein of human immunodeficiency virus type 1.","publicationDate":"1994","journal":"J. Virol.","firstPage":"704","lastPage":"712","volume":"68"},"referencePositions":["SUBCELLULAR LOCATION"]},{"citation":{"id":"7474141","citationType":"journal article","authors":["Goncalves J.","Shi B.","Yang X.","Gabuzda D."],"citationCrossReferences":[{"database":"PubMed","id":"7474141"},{"database":"DOI","id":"10.1128/jvi.69.11.7196-7204.1995"}],"title":"Biological activity of human immunodeficiency virus type 1 Vif requires membrane targeting by C-terminal basic domains.","publicationDate":"1995","journal":"J. Virol.","firstPage":"7196","lastPage":"7204","volume":"69"},"referencePositions":["MUTAGENESIS OF 157-LYS--LYS-160 AND 173-ARG--ARG-184"]},{"citation":{"id":"8523563","citationType":"journal article","authors":["Karczewski M.K.","Strebel K."],"citationCrossReferences":[{"database":"PubMed","id":"8523563"},{"database":"DOI","id":"10.1128/jvi.70.1.494-507.1996"}],"title":"Cytoskeleton association and virion incorporation of the human immunodeficiency virus type 1 Vif protein.","publicationDate":"1996","journal":"J. Virol.","firstPage":"494","lastPage":"507","volume":"70"},"referencePositions":["SUBCELLULAR LOCATION"]},{"citation":{"id":"8626571","citationType":"journal article","authors":["Yang X.","Goncalves J.","Gabuzda D."],"citationCrossReferences":[{"database":"PubMed","id":"8626571"},{"database":"DOI","id":"10.1074/jbc.271.17.10121"}],"title":"Phosphorylation of Vif and its role in HIV-1 replication.","publicationDate":"1996","journal":"J. Biol. Chem.","firstPage":"10121","lastPage":"10129","volume":"271"},"referencePositions":["PHOSPHORYLATION AT SER-144; THR-155 AND THR-188","MUTAGENESIS OF SER-144"]},{"citation":{"id":"8970997","citationType":"journal article","authors":["Goncalves J.","Korin Y.","Zack J.","Gabuzda D."],"citationCrossReferences":[{"database":"PubMed","id":"8970997"},{"database":"DOI","id":"10.1128/jvi.70.12.8701-8709.1996"}],"title":"Role of Vif in human immunodeficiency virus type 1 reverse transcription.","publicationDate":"1996","journal":"J. Virol.","firstPage":"8701","lastPage":"8709","volume":"70"},"referencePositions":["FUNCTION"]},{"citation":{"id":"8709234","citationType":"journal article","authors":["Camaur D.","Trono D."],"citationCrossReferences":[{"database":"PubMed","id":"8709234"},{"database":"DOI","id":"10.1128/jvi.70.9.6106-6111.1996"}],"title":"Characterization of human immunodeficiency virus type 1 Vif particle incorporation.","publicationDate":"1996","journal":"J. Virol.","firstPage":"6106","lastPage":"6111","volume":"70"},"referencePositions":["INCORPORATION IN THE VIRION"]},{"citation":{"id":"9371595","citationType":"journal article","authors":["Bouyac M.","Courcoul M.","Bertoia G.","Baudat Y.","Gabuzda D.","Blanc D.","Chazal N.","Boulanger P.","Sire J.","Vigne R.","Spire B."],"citationCrossReferences":[{"database":"PubMed","id":"9371595"},{"database":"DOI","id":"10.1128/jvi.71.12.9358-9365.1997"}],"title":"Human immunodeficiency virus type 1 Vif protein binds to the Pr55Gag precursor.","publicationDate":"1997","journal":"J. Virol.","firstPage":"9358","lastPage":"9365","volume":"71"},"referencePositions":["INTERACTION WITH PR55GAG"]},{"citation":{"id":"9792705","citationType":"journal article","authors":["Yang X.","Gabuzda D."],"citationCrossReferences":[{"database":"PubMed","id":"9792705"},{"database":"DOI","id":"10.1074/jbc.273.45.29879"}],"title":"Mitogen-activated protein kinase phosphorylates and regulates the HIV-1 Vif protein.","publicationDate":"1998","journal":"J. Biol. Chem.","firstPage":"29879","lastPage":"29887","volume":"273"},"referencePositions":["PHOSPHORYLATION AT THR-96 AND SER-165 BY MAP4K1","PROTEIN SEQUENCE OF 159-164 AND 94-98","MUTAGENESIS OF THR-96"]},{"citation":{"id":"14564014","citationType":"journal article","authors":["Yu X.","Yu Y.","Liu B.","Luo K.","Kong W.","Mao P.","Yu X.F."],"citationCrossReferences":[{"database":"PubMed","id":"14564014"},{"database":"DOI","id":"10.1126/science.1089591"}],"title":"Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex.","publicationDate":"2003","journal":"Science","firstPage":"1056","lastPage":"1060","volume":"302"},"referencePositions":["FUNCTION"]},{"citation":{"id":"14672928","citationType":"journal article","authors":["Mehle A.","Strack B.","Ancuta P.","Zhang C.","McPike M.","Gabuzda D."],"citationCrossReferences":[{"database":"PubMed","id":"14672928"},{"database":"DOI","id":"10.1074/jbc.m313093200"}],"title":"Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway.","publicationDate":"2004","journal":"J. Biol. Chem.","firstPage":"7792","lastPage":"7798","volume":"279"},"referencePositions":["FUNCTION","MUTAGENESIS OF CYS-114; CYS-133 AND THR-188"]},{"citation":{"id":"15177194","citationType":"journal article","authors":["Rose K.M.","Marin M.","Kozak S.L.","Kabat D."],"citationCrossReferences":[{"database":"PubMed","id":"15177194"},{"database":"DOI","id":"10.1016/j.molmed.2004.04.008"}],"title":"The viral infectivity factor (Vif) of HIV-1 unveiled.","publicationDate":"2004","journal":"Trends Mol. Med.","firstPage":"291","lastPage":"297","volume":"10"},"referencePositions":["REVIEW"]},{"citation":{"id":"15752743","citationType":"journal article","authors":["Douaisi M.","Dussart S.","Courcoul M.","Bessou G.","Lerner E.C.","Decroly E.","Vigne R."],"citationCrossReferences":[{"database":"PubMed","id":"15752743"},{"database":"DOI","id":"10.1016/j.bbrc.2005.02.057"}],"title":"The tyrosine kinases Fyn and Hck favor the recruitment of tyrosine-phosphorylated APOBEC3G into vif-defective HIV-1 particles.","publicationDate":"2005","journal":"Biochem. Biophys. Res. Commun.","firstPage":"917","lastPage":"924","volume":"329"},"referencePositions":["INTERACTION WITH HOST HCK AND FYN"]},{"citation":{"id":"17522216","citationType":"journal article","authors":["Russell R.A.","Pathak V.K."],"citationCrossReferences":[{"database":"PubMed","id":"17522216"},{"database":"DOI","id":"10.1128/jvi.00395-07"}],"title":"Identification of two distinct human immunodeficiency virus type 1 Vif determinants critical for interactions with human APOBEC3G and APOBEC3F.","publicationDate":"2007","journal":"J. Virol.","firstPage":"8201","lastPage":"8210","volume":"81"},"referencePositions":["INTERACTION WITH HOST APOBEC3F AND APOBEC3G"]},{"citation":{"id":"17056089","citationType":"journal article","authors":["Wang J.","Shackelford J.M.","Casella C.R.","Shivers D.K.","Rapaport E.L.","Liu B.","Yu X.F.","Finkel T.H."],"citationCrossReferences":[{"database":"PubMed","id":"17056089"},{"database":"DOI","id":"10.1016/j.virol.2006.09.026"}],"title":"The Vif accessory protein alters the cell cycle of human immunodeficiency virus type 1 infected cells.","publicationDate":"2007","journal":"Virology","firstPage":"243","lastPage":"252","volume":"359"},"referencePositions":["FUNCTION IN CELL CYCLE ARREST"]},{"citation":{"id":"18619467","citationType":"journal article","authors":["He Z.","Zhang W.","Chen G.","Xu R.","Yu X.F."],"citationCrossReferences":[{"database":"PubMed","id":"18619467"},{"database":"DOI","id":"10.1016/j.jmb.2008.06.061"}],"title":"Characterization of conserved motifs in HIV-1 Vif required for APOBEC3G and APOBEC3F interaction.","publicationDate":"2008","journal":"J. Mol. Biol.","firstPage":"1000","lastPage":"1011","volume":"381"},"referencePositions":["INTERACTION WITH HOST APOBEC3F AND APOBEC3G"]},{"citation":{"id":"19128510","citationType":"journal article","authors":["Izumi T.","Takaori-Kondo A.","Shirakawa K.","Higashitsuji H.","Itoh K.","Io K.","Matsui M.","Iwai K.","Kondoh H.","Sato T.","Tomonaga M.","Ikeda S.","Akari H.","Koyanagi Y.","Fujita J.","Uchiyama T."],"citationCrossReferences":[{"database":"PubMed","id":"19128510"},{"database":"DOI","id":"10.1186/1742-4690-6-1"}],"title":"MDM2 is a novel E3 ligase for HIV-1 Vif.","publicationDate":"2009","journal":"Retrovirology","firstPage":"1","lastPage":"1","volume":"6"},"referencePositions":["INTERACTION WITH HOST MDM2"]},{"citation":{"id":"19369217","citationType":"journal article","authors":["Kataropoulou A.","Bovolenta C.","Belfiore A.","Trabatti S.","Garbelli A.","Porcellini S.","Lupo R.","Maga G."],"citationCrossReferences":[{"database":"PubMed","id":"19369217"},{"database":"DOI","id":"10.1093/nar/gkp226"}],"title":"Mutational analysis of the HIV-1 auxiliary protein Vif identifies independent domains important for the physical and functional interaction with HIV-1 reverse transcriptase.","publicationDate":"2009","journal":"Nucleic Acids Res.","firstPage":"3660","lastPage":"3669","volume":"37"},"referencePositions":["INTERACTION WITH THE REVERSE TRANSCRIPTASE"]},{"citation":{"id":"19910370","citationType":"journal article","authors":["Mercenne G.","Bernacchi S.","Richer D.","Bec G.","Henriet S.","Paillart J.C.","Marquet R."],"citationCrossReferences":[{"database":"PubMed","id":"19910370"},{"database":"DOI","id":"10.1093/nar/gkp1009"}],"title":"HIV-1 Vif binds to APOBEC3G mRNA and inhibits its translation.","publicationDate":"2010","journal":"Nucleic Acids Res.","firstPage":"633","lastPage":"646","volume":"38"},"referencePositions":["FUNCTION"]}],"uniProtKBCrossReferences":[{"database":"EMBL","id":"K03455","properties":[{"key":"ProteinId","value":"AAB50260.1"},{"key":"Status","value":"-"},{"key":"MoleculeType","value":"Genomic_RNA"}]},{"database":"RefSeq","id":"NP_057851.1","properties":[{"key":"NucleotideSequenceId","value":"NC_001802.1"}]},{"database":"SMR","id":"P69723","properties":[{"key":"Description","value":"-"}]},{"database":"BioGRID","id":"1205539","properties":[{"key":"Interactions","value":"64"}]},{"database":"DIP","id":"DIP-61318N","properties":[{"key":"Description","value":"-"}]},{"database":"IntAct","id":"P69723","properties":[{"key":"Interactions","value":"5"}]},{"database":"iPTMnet","id":"P69723","properties":[{"key":"Description","value":"-"}]},{"database":"GeneID","id":"155459","properties":[{"key":"Description","value":"-"}]},{"database":"KEGG","id":"vg:155459","properties":[{"key":"Description","value":"-"}]},{"database":"Reactome","id":"R-HSA-162585","properties":[{"key":"PathwayName","value":"Uncoating of the HIV Virion"}]},{"database":"Reactome","id":"R-HSA-162588","properties":[{"key":"PathwayName","value":"Budding and maturation of HIV virion"}]},{"database":"Reactome","id":"R-HSA-162592","properties":[{"key":"PathwayName","value":"Integration of provirus"}]},{"database":"Reactome","id":"R-HSA-162594","properties":[{"key":"PathwayName","value":"Early Phase of HIV Life Cycle"}]},{"database":"Reactome","id":"R-HSA-164516","properties":[{"key":"PathwayName","value":"Minus-strand DNA synthesis"}]},{"database":"Reactome","id":"R-HSA-164525","properties":[{"key":"PathwayName","value":"Plus-strand DNA synthesis"}]},{"database":"Reactome","id":"R-HSA-164843","properties":[{"key":"PathwayName","value":"2-LTR circle formation"}]},{"database":"Reactome","id":"R-HSA-173107","properties":[{"key":"PathwayName","value":"Binding and entry of HIV virion"}]},{"database":"Reactome","id":"R-HSA-175474","properties":[{"key":"PathwayName","value":"Assembly Of The HIV Virion"}]},{"database":"Reactome","id":"R-HSA-175567","properties":[{"key":"PathwayName","value":"Integration of viral DNA into host genomic DNA"}]},{"database":"Reactome","id":"R-HSA-177539","properties":[{"key":"PathwayName","value":"Autointegration results in viral DNA circles"}]},{"database":"Reactome","id":"R-HSA-180585","properties":[{"key":"PathwayName","value":"Vif-mediated degradation of APOBEC3G"}]},{"database":"Reactome","id":"R-HSA-180689","properties":[{"key":"PathwayName","value":"APOBEC3G mediated resistance to HIV-1 infection"}]},{"database":"Reactome","id":"R-HSA-180910","properties":[{"key":"PathwayName","value":"Vpr-mediated nuclear import of PICs"}]},{"database":"PRO","id":"PR:P69723","properties":[{"key":"Description","value":"-"}]},{"database":"Proteomes","id":"UP000002241","properties":[{"key":"Component","value":"Genome"}]},{"database":"GO","id":"GO:0030430","properties":[{"key":"GoTerm","value":"C:host cell cytoplasm"},{"key":"GoEvidenceType","value":"IEA:UniProtKB-SubCell"}]},{"database":"GO","id":"GO:0020002","properties":[{"key":"GoTerm","value":"C:host cell plasma membrane"},{"key":"GoEvidenceType","value":"IEA:UniProtKB-SubCell"}]},{"database":"GO","id":"GO:0016020","properties":[{"key":"GoTerm","value":"C:membrane"},{"key":"GoEvidenceType","value":"IEA:UniProtKB-UniRule"}]},{"database":"GO","id":"GO:0044423","properties":[{"key":"GoTerm","value":"C:virion component"},{"key":"GoEvidenceType","value":"IEA:UniProtKB-UniRule"}]},{"database":"GO","id":"GO:0042802","properties":[{"key":"GoTerm","value":"F:identical protein binding"},{"key":"GoEvidenceType","value":"IPI:IntAct"}],"evidences":[{"evidenceCode":"ECO:0000353","source":"PubMed","id":"17132731"}]},{"database":"GO","id":"GO:0008289","properties":[{"key":"GoTerm","value":"F:lipid binding"},{"key":"GoEvidenceType","value":"EXP:DisProt"}],"evidences":[{"evidenceCode":"ECO:0000269","source":"PubMed","id":"19218568"}]},{"database":"GO","id":"GO:0003723","properties":[{"key":"GoTerm","value":"F:RNA binding"},{"key":"GoEvidenceType","value":"IEA:UniProtKB-UniRule"}]},{"database":"GO","id":"GO:0019079","properties":[{"key":"GoTerm","value":"P:viral genome replication"},{"key":"GoEvidenceType","value":"EXP:DisProt"}],"evidences":[{"evidenceCode":"ECO:0000269","source":"PubMed","id":"7474141"},{"evidenceCode":"ECO:0000269","source":"PubMed","id":"8970997"}]},{"database":"DisProt","id":"DP00875","properties":[{"key":"Description","value":"-"}]},{"database":"HAMAP","id":"MF_04081","properties":[{"key":"EntryName","value":"HIV_VIF"},{"key":"MatchStatus","value":"1"}]},{"database":"InterPro","id":"IPR000475","properties":[{"key":"EntryName","value":"Vif"}]},{"database":"Pfam","id":"PF00559","properties":[{"key":"EntryName","value":"Vif"},{"key":"MatchStatus","value":"1"}]},{"database":"PRINTS","id":"PR00349","properties":[{"key":"EntryName","value":"VIRIONINFFCT"}]}],"sequence":{"value":"MENRWQVMIVWQVDRMRIRTWKSLVKHHMYVSGKARGWFYRHHYESPHPRISSEVHIPLGDARLVITTYWGLHTGERDWHLGQGVSIEWRKKRYSTQVDPELADQLIHLYYFDCFSDSAIRKALLGHIVSPRCEYQAGHNKVGSLQYLALAALITPKKIKPPLPSVTKLTEDRWNKPQKTKGHRGSHTMNGH","length":192,"molWeight":22513,"crc64":"D22589F3955CBE40","md5":"E35566FC2AC525BF03A14E27E4F76C83"},"extraAttributes":{"countByCommentType":{"FUNCTION":1,"SUBUNIT":1,"INTERACTION":2,"SUBCELLULAR LOCATION":1,"INDUCTION":1,"DOMAIN":2,"PTM":3,"MISCELLANEOUS":3,"SIMILARITY":1},"countByFeatureType":{"Chain":3,"Region":8,"Motif":2,"Site":1,"Modified residue":5,"Mutagenesis":9},"uniParcId":"UPI000000078E"}}